Search for members, bills, votes, committees, hearings, and nominations
The Women and Lung Cancer Research and Preventive Services Act of 2025 aims to address the disproportionate impact of lung cancer on women. If enacted, the bill would require the Department of Health and Human Services to lead a multi-agency review alongside the Departments of Defense and Veterans Affairs. This review would evaluate the current state of federal research and identify gaps in understanding why lung cancer rates and outcomes differ for women compared to men, including factors like genetics and environmental exposures.
Beyond research, the legislation proposes to improve how the government handles prevention and early detection. It would assess existing public health strategies to increase the use of lung cancer screenings and biomarker testing, which can help doctors tailor treatments to individual patients. The bill also seeks to launch new public awareness campaigns to educate citizens about the importance of early diagnosis and the specific risks women face, regardless of their smoking history.
Ultimately, the bill aims to create a more coordinated federal response to the leading cause of cancer death in the United States. Within two years of becoming law, the Secretary of Health and Human Services would be required to submit a report to Congress detailing findings from the review and providing recommendations for legislative or administrative changes to improve health outcomes for women and underserved communities.
AI-generated summary
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jan 15, 2026
Jan 15, 2026 · 15:00
The Senate Committee on Health, Education, Labor, and Pensions held a business meeting on January 15, 2026, to consider four separate bills addressing different public health and safety concerns. The bills under consideration were S. 272, the Protect Infant Formula from Contamination Act, which would require testing of infant formula for microorganisms and toxic elements; S. 921, Tyler's Law, which would direct the Secretary of Health and Human Services to issue guidance on fentanyl testing in hospital emergency departments for overdose patients; S. 1157, the Women and Lung Cancer Research and Preventive Services Act of 2025, which would direct a review of lung cancer research status in women and underserved populations; and S. 2169, the Rural Hospital Cybersecurity Enhancement Act, which would require development of a comprehensive cybersecurity workforce development strategy for rural hospitals. As a business meeting rather than a hearing with witnesses, this session focused on committee consideration of the bills rather than testimony from outside parties. No witnesses were listed for this meeting, indicating the committee proceeded with its own deliberations on the proposed legislation. A business meeting of this type represents an early procedural step in the legislative process. The committee's consideration of these bills does not guarantee they will advance further. The next steps would depend on committee votes and decisions regarding whether to report the bills favorably to the full Senate for consideration.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jan 15, 2026
Jan 15, 2026 · 15:00
The Senate Committee on Health, Education, Labor, and Pensions held a business meeting on January 15, 2026, to consider four separate bills addressing different public health and safety concerns. The bills under consideration were S. 272, the Protect Infant Formula from Contamination Act, which would require testing of infant formula for microorganisms and toxic elements; S. 921, Tyler's Law, which would direct the Secretary of Health and Human Services to issue guidance on fentanyl testing in hospital emergency departments for overdose patients; S. 1157, the Women and Lung Cancer Research and Preventive Services Act of 2025, which would direct a review of lung cancer research status in women and underserved populations; and S. 2169, the Rural Hospital Cybersecurity Enhancement Act, which would require development of a comprehensive cybersecurity workforce development strategy for rural hospitals. As a business meeting rather than a hearing with witnesses, this session focused on committee consideration of the bills rather than testimony from outside parties. No witnesses were listed for this meeting, indicating the committee proceeded with its own deliberations on the proposed legislation. A business meeting of this type represents an early procedural step in the legislative process. The committee's consideration of these bills does not guarantee they will advance further. The next steps would depend on committee votes and decisions regarding whether to report the bills favorably to the full Senate for consideration.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Jan 28, 2026
Congress
119th Congress
Introduced
Mar 26, 2025
No CBO cost estimate has been published for this bill.
